Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 9.2% - Here's What Happened

Key Points

• Bayer Aktiengesellschaft's shares dropped by 9.2% during mid-day trading, reaching a low of $7.23, with trading volume declining significantly to 328,358 shares.
• Recent analyst ratings show mixed reviews for Bayer, with one firm upgrading the stock to a "strong-buy," while another downgraded it to "hold," resulting in an average rating of "Buy."
• The company reported earnings of $0.65 per share for the last quarter, exceeding expectations, with a revenue of $15.27 billion against estimates of $13.39 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s share price was down 9.2% during mid-day trading on Wednesday . The company traded as low as $7.23 and last traded at $7.23. Approximately 328,358 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 802,480 shares. The stock had previously closed at $7.96.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on BAYRY shares. Wall Street Zen cut shares of Bayer Aktiengesellschaft from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Kepler Capital Markets upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. The Goldman Sachs Group upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Finally, Hsbc Global Res upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 11th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy".

Bayer Aktiengesellschaft Price Performance

The company has a debt-to-equity ratio of 1.07, a quick ratio of 0.79 and a current ratio of 1.25. The business's 50 day simple moving average is $7.81 and its 200-day simple moving average is $6.70. The stock has a market capitalization of $28.53 billion, a price-to-earnings ratio of -7.89 and a beta of 0.91.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.63 by $0.02. Bayer Aktiengesellschaft had a negative net margin of 7.26% and a positive return on equity of 13.94%. The business had revenue of $15.27 billion during the quarter, compared to analyst estimates of $13.39 billion. Research analysts anticipate that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.